Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism

The prevalence of androgen deficiency in reproductive-aged men is increasing and needs new approach to long-term hypogonadism treatment that can preserve fertility. An open non-controlled pilot study included 18 men with eugonadotropic hypogonadism, who received transdermal testosterone gel treatment for 3 months. Sperm analysis was made before treatment and after 3 month of testosterone therapy. Testosterone level was normalized in all patients, but no negative effect was observed on spermatogenesis. Testosterone gel therapy may be a therapy of choice in hypogonadal men of reproductive age but further studies are needed. © 2014 Informa UK Ltd.

Авторы
George M.1 , Yulia T. 2 , Svetlana K. 2
Язык
Английский
Страницы
22-24
Статус
Опубликовано
Том
30
Год
2014
Организации
  • 1 Andrology and Endocrinology Department, Center for Reproductive Medicine MAMA, Moscow, Russian Federation
  • 2 Endocrinology Department, Peoples' Friendship University of Russia, Moscow, Russian Federation
Ключевые слова
Androgel; Androgen deficiency; Hypogonadism; Sperm; Spermatogenesis; Testosterone; Testosterone gel
Дата создания
19.10.2018
Дата изменения
19.10.2018
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/4925/
Поделиться

Другие записи